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ABSTRACT 
Members of the ROK family of proteins are mostly transcriptional regulators and kinases that 
generally relate to the control of primary metabolism, whereby its member glucose kinase 
acts as the central control protein in carbon control in Streptomyces. Here we show that 25	  
deletion of SCO6008 (rok7B7) strongly affects carbon catabolite repression (CCR), growth 
and antibiotic production in Streptomyces coelicolor. Deletion of SCO7543 also affected 
antibiotic production, while no major changes were observed after deletion of the rok family 
genes SCO0794, SCO1060, SCO2846, SCO6566 or SCO6600. Global expression profiling 
of the rok7B7 mutant by proteomics and microarray analysis revealed strong up-regulation of 30	  
the xylose transporter operon xylFGH, which lies immediately downstream of rok7B7, 
consistent with the improved growth and delayed development of the mutant on xylose. The 
enhanced CCR, which was especially obvious on rich or xylose-containing media, correlated 
with elevated expression of glucose kinase and of the glucose transporter GlcP. In liquid-
grown cultures, expression of the biosynthetic enzymes for production of prodigionines 35	  
(Red), siderophores and calcium dependent antibiotic (Cda) was enhanced in the mutant, 
and overproduction of Red was corroborated by MALDI-ToF analysis. These data present 
Rok7B7 as a pleiotropic regulator of growth, CCR and antibiotic production in Streptomyces. 
 
 40	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INTRODUCTION 
Streptomyces are high G+C soil bacteria, well known as the major producers of antibiotics 45	  
and natural products. Under nutrient-limited conditions they undergo complex morphological 
changes, which result in formation of aerial mycelium and chains of spores. The 
developmental program coincides with production of antibiotics (1). Sequencing of the 
genome of the model organism Streptomyces coelicolor A3(2) identified around 7825 genes 
and more than 20 secondary metabolite gene clusters (2). Over 12% of the genome encodes 50	  
predicted regulatory proteins, underlining the complexity of the regulatory networks that 
govern the transcriptional control of cell differentiation, secondary metabolite production and 
signaling cascades. 
 Carbon source regulation is a major factor in the control of morphological 
differentiation and secondary metabolism (recently reviewed in (3, 4)). We previously showed 55	  
that changes in N-acetylglucosamine metabolism have a major effect on the production of 
pigmented antibiotics in S. coelicolor (5, 6). This is in part explained by the fact that 
glucosamine-6P is an allosteric effector of the global regulator DasR, which represses 
antibiotic production (7, 8), but it is likely that other factors play a role, including global carbon 
control mechanisms. Carbon catabolite repression (CCR) allows bacteria to utilize a 60	  
preferred carbon source (such as glucose) when exposed to multiple carbohydrates. In 
Gram-negative bacteria and low-G+C Gram-positive bacteria such as Escherichia coli and 
Bacillus subtilis, the phosphoenolpyruvate-dependent phosphotransferase system (PTS) 
plays a major role in carbon regulation (9, 10). During PTS-mediated carbon source 
internalization, a phosphoryl group is transferred from the glycolytic intermediate 65	  
phosphoenolpyruvate, via the PTS enzymes phosphotransferase enzyme I (EI), the histidine 
phosphor-carrier protein (HPr), and Enzyme IIA (EIIA) onto the incoming carbon source. The 
PTS-mediated transport triggers the cAMP-receptor protein (Crp) in Gram-negative bacteria, 
and the catabolite control protein CcpA in low-GC Gram-positive bacteria (9). In 
Streptomyces, GlcNAc and fructose transport depend on the PTS, but glucose transport is 70	  
mediated via the MFS transporter GlcP (11). In terms of global regulation, streptomycetes 
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lack a CcpA orthologue, while Crp is present but does not play a role in CCR (12). In 
contrast, in streptomycetes CCR largely depends on the enzyme glucose kinase (Glk; 
SCO2126), and deletion of the glkA gene results in global loss of CCR (13). Interestingly, 
CCR is independent of the Glk enzymatic activity and the flux of glucose, and replacing Glk 75	  
of S. coelicolor by that of Zymomonas mobilis restores normal glycolysis, but not CCR (13).  
 The crystal structure of Glk of Streptomyces griseus was recently resolved (14). The 
Streptomyces Glk protein belongs to group III of the glucokinases, which contain a ROK 
signature (Pfam PF00480) that is found in a diverse family of proteins (ROK stands for 
repressors, open reading frames and kinases; (15)). Some 5,000 ROK-family proteins have 80	  
been identified so far, mostly in prokaryotes, but family members are found in all kingdoms of 
life (16). ROK kinases contain a conserved N-terminal ATP binding motif (DxGxT), while 
ROK regulators contain a canonical helix-turn–helix DNA binding motif in their N-terminal 
domain. In E. coli, the ROK-family proteins NagC and Mlc are involved in the control of 
GlcNAc and glucose-PTS genes, respectively (17, 18). The S. coelicolor genome contains 25 85	  
genes encoding putative ROK-family proteins, twelve of which contain a DNA binding motif. 
Additionally, sixteen of the ROK proteins contain a zinc-binding motif, which conforms to the 
consensus (GHX(9–11)CXCGX2G(C/H)XE) and was shown to be essential for function of E. 
coli Mlc and B. subtilis Glk (19, 20). Interestingly, SCO6008 (Rok7B7) was identified as an 
activator of actinorhodin biosynthesis in a mass spectrometry-based assay for proteins that 90	  
bind upstream of the regulatory gene actII-ORF4 (21), and expression of a metagenomic 
library in Streptomyces lividans revealed that the rok7B7 homolog rep accelerates antibiotic 
production and sporulation (22). Additionally, Rok7B7 was recently implicated in CCR in S. 
coelicolor (23). 
In search of new regulatory genes that may play a role in carbon-dependent control of 95	  
antibiotic production, we here describe the mutational analysis of seven of the rok genes of 
S. coelicolor. These seven genes all contain a DNA binding domain and a cysteine motif 
involved in zinc binding (24), and include the three closest relatives of rep. Deletion of 
rok7B7 (SCO6008) resulted in global changes in antibiotic production and morphological 
	   5	  
differentiation under various growth conditions. Detailed phenotypic and genome-wide 100	  
transcriptome and proteome analysis of the rok7B7 null mutant established a relationship 
between Rok7B7 and CCR, depending on the nutritional status of the environment. 
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MATERIALS AND METHODS 
 105	  
Bacterial strains and growth conditions 
All bacterial strains are listed in Supplemental Table S1. Escherichia coli JM109 (25) and 
ET12567 (26) were used for routine cloning procedures and for extracting non-methylated 
DNA, respectively. Streptomyces coelicolor A3(2) M145 was the parent for all mutants 
described in this work. S. coelicolor M512 (M145 ΔactII-ORF4 ΔredD; (27)) lacks the 110	  
pathway-specific activator genes for actinorhodin and undecylprodigiosin biosynthetic 
clusters and therefore fails to produce these antibiotics, although the strain has an intact 
biosynthetic machinery (28). All media and routine Streptomyces techniques are described in 
the Streptomyces manual (26). E. coli cells were grown in Luria–Bertani broth (LB) at 37°C. 
Phenotypic characterization of Streptomyces mutants was carried out on minimal media 115	  
(MM) and on R2YE- (ie. lacking glucose) agar plates (26) with 1% of carbon sources as 
indicated. SFM (soy flour mannitol) agar plates were used to prepare spore suspensions. For 
growth curves, liquid NNMP (26) was used with low (0.1% w/v) concentration of casamino 
acids. An adapted NMMP medium was used for 14N/15N-labeling, containing per L: 2 g 
NH4Cl, 1 g algal amino acids, 0.6 g MgSO4⋅7 H2O, 50 g polyethylene glycol 6000 (NBS 120	  
biologicals, Huntingdon, UK), 0.1 mg ZnSO4⋅7 H2O, 0.1 mg FeSO4⋅7 H2O, 0.1 mg MnCl2⋅7 
H2O, 0.1 mg CaCl2, 15 mM Na/K phosphate buffer (pH 6.8), and 5 g mannitol. For 15N-
labeling, NH4Cl (>99% 15N) and algal amino acids (>98% 15N) were added as 15N-labeled 
compounds (Cambridge Stable Isotopes, Andover, MA). 
 125	  
Plasmids and constructs 
All constructs described in this work are listed in Supplemental Table S2. 
Constructs for gene-replacement and deletion mutants 
The strategy for creating knock-out mutants is based on the unstable multi-copy vector 
pWHM3 (29) as described previously (11). For each knock-out construct roughly 1.5 kb of 130	  
upstream and downstream region of the respective genes were amplified by PCR from the S. 
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coelicolor M145 genome. The upstream region was thereby cloned as an EcoRI-XbaI 
fragment, and the downstream part as an XbaI-HindIII fragment, and these were ligated into 
EcoRI-HindIII-digested pWHM3 (for the exact location of the oligonucleotides see Table S3). 
In this way, an XbaI site was engineered in-between the flanking regions of the gene of 135	  
interest. This was then used to insert the apramycin resistance cassette aacC4 flanked by 
loxP sites, using engineered XbaI sites. The presence of the loxP recognition sites allows the 
efficient removal of the apramycin resistance cassette following the introduction of a plasmid 
pUWLcre expressing the Cre recombinase (30, 31). We constructed the knock-out plasmids 
pGAM8 to pGAM14 for the single gene replacement of SCO0794, SCO1060, SCO2846, 140	  
SCO6008, SCO6566, SCO6600, SCO7543, respectively. To analyse correctness of the 
mutants, PCRs were done on mycelium from liquid-grown MM cultures, with oligonucleotide 
pairs as in Table S3. 
 For complementation of the GAM33 mutant (Δrok7B7) the integrative vector 
pSET152 (32) harbouring a recombinant rok7B7 gene along with 250 bp promoter region 145	  
and the stop codon replaced by the sequence 5’-
ATGGACTACAAGGACCACGACGGCGACTACAAGGACCACGACATCGACTACAAGGACG
ACGACGACAAGTAGAGCACGGATGGCACCGTTGTCATCTCGTTAAGGATTTACTTCTT 
was used. The recombinant rok7B7 gene was synthesized that allows production of Rok7B7 
containing a C-terminal triple FLAG-tag epitope (GenScript, La Jolla, USA). 150	  
 
Agarase assays 
Spores of S. coelicolor M145, its rok7B7 null mutant GAM33 and the complemented mutant 
were spotted onto minimal media (MM) and on R2YE- (-glucose) agar plates (26) with 1% 
(w/v) of different carbon sources as indicated. After 3 days of growth the agarase production 155	  
was assessed by measuring the zones of clearing of the agar around the mycelial spot and 
related to the biomass. Experiments were done several times, with highly similar results. 
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Proteomics analysis 
S. coelicolor M145 and its rok7B7 deletion mutant GAM33 were grown in liquid minimal 160	  
media containing either 14N or 15N as the sole nitrogen source, as described above, until late 
logarithmic phase when antibiotic production became apparent due to color changes of the 
growth medium. This was repeated for a label swap experiment in which the nitrogen 
sources were exchanged between strains. 
At indicated time points mycelium was harvested by centrifugation, washed, and 165	  
sonicated for 5 min at 12 W output power using 5 s on / 5 s off intervals in 100 mM Tris/HCl 
(pH 7.5), 10 mM MgCl2, 5 mM dithiothreitol (DTT). Debris was removed by centrifugation at 
16,000 g for 10 min at 4 °C. Protein concentration of the extracts was determined using a 
Bradford protein assay, using BSA as standard. Secreted proteins were precipitated from the 
growth medium in chloroform / methanol as described (33). Protein pellets were dissolved in 170	  
1% (w/v) SDS, 50 mM Tris/HCl pH 7.5 at 70 °C for 10 min and the amount of protein 
measured using a protein DC assay (Bio-Rad, Hercules, CA), using BSA as a standard.  
To perform quantitative proteomics, 14N- and 15N-labeled media or mycelial extracts were 
mixed 1:1 for protein content, and proteins precipitated using chloroform / methanol (33). 
Protein pellets were heated at 95 °C for 5 min in SDS-PAGE sample buffer and proteins 175	  
separated on mini-protean TGX anyKD gels (Bio-Rad). Gels were stained with Coomassie 
brilliant blue and gel lanes were cut in ±15 pieces. Cysteines were reduced with DTT and 
modified with iodoacetamide, proteins in-gel digested O/N with trypsin, and peptides 
extracted, all as described (34). Acidified peptides were purified and concentrated using C18-
stagetips (35) as described. Peptides were analyzed on a Surveyor nanoLC system 180	  
(Thermo, Waltham, MA) hyphenated to an LTQ-Orbitrap mass spectrometer (Thermo), as 
described (36).  
Peak lists were extracted and charge states determined using DTASuperCharge 
(version 2.0b1) (37). Spectra were searched against the Streptomyces coelicolor genome 
database (Sanger Institute, Hinxton, UK) using Mascot (Matrix Science, London, UK; version 185	  
2.2.03) with a parent ion tolerance of 10 ppm and a fragment ion mass tolerance of 0.9 Da. 
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15N-metabolic labeling was specified as quantification method. Fixed and variable 
modifications were the iodoacetamide derivative of cysteine and oxidation of methionine, 
respectively. Extracted ion currents (XIC) of identified peptides and their relative ratios were 
derived using MSQuant (version 2.0a81) (37) and a correction algorithm for incomplete 15N 190	  
incorporation rates was applied (38). StatQuant (version 1.2.3) (39) was used for peptide 
ratio outlier removal based on Z-values (n > 3), after which relative protein ratios were 
calculated by averaging peptide ratios. To compensate for errors in the mixing of samples, 
protein ratios were normalized based on the median ratio or, in case of the time series 
experiment, based on the elongation factor G (SCO4661, fusA) ratio. 195	  
StatQuant was also used to determine whether the observed difference in amount of 
protein between the two samples was significant using a one sample Student’s t-test. Protein 
ratios with p < 0.1 were accepted and compared to protein ratios of the label swap 
experiment using an additional one sample Student’s t-test. Proteins that demonstrated 
opposing ratios between the original and label swap experiment (p > 0.5), or were present in 200	  
only one of the experiments were eliminated.  
 
MALDI-ToF MS analysis 
The same mycelial samples as those used for proteomics were also extracted with methanol 
and extract mixed 1:1 (v/v) with a saturated α-cyano-4-hydroxycinnamic acid solution in 50% 205	  
(v/v) acetonitrile / 0.05% (v/v) trifluoroacetic acid, 1 µl was spotted on a MALDI target plate, 
and samples were measured on a Brucker microflex LRF mass spectrometer in the positive 
ion reflectron mode using delayed extraction. For each spectrum, at least 1,000 shots were 
acquired at 60 Hz.  
 210	  
RNA isolation and DNA microarray analysis and validation  
For transcript analysis, total RNA was isolated as described (40) from surface-grown mycelia 
of S. coelicolor M145 and its rok7B7 null mutant, cultivated on MM agar plates with mannitol 
(1% w/v) as the sole carbon source (plates were covered with cellophane discs). Two 
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independent biological replicate experiments were performed. Samples were taken at 14h 215	  
(early vegetative growth), 24 h (vegetative growth), 30 h (early aerial growth), 36 h (aerial 
growth), 42 h (early sporulation) and 54 h (sporulation). Total RNA was purified using the 
Kirby-mix protocol (26). DNaseI treatment was used to fully remove any traces of DNA. 
Before use, the RNA samples were checked for integrity on an Agilent 2100 Bioanalyzer 
(Agilent Technologies) and lack of DNA was checked by RT-PCR without reverse 220	  
transcriptase. cDNA preparation, labeling and hybridization was performed as previously 
described (41, 42). For the microarray analysis 4 × 44K whole genome Streptomyces arrays 
were used, manufactured by Agilent Technologies (42). The filtered data sets were analyzed 
using rank products analysis (43) via the Rank-Prod package in R (version 2.5.0) (44). 
Differentially expressed genes were identified as demonstrating a > 2 fold change in 225	  
expression between the parental strain M145 (wild-type) and the rok7B7 mutant. To verify 
the output from the microarray analysis, semi-quantitative RT-PCR analysis was carried out 
as described previously (45). For each RT-PCR reaction 200 ng of RNA was used 
(concentration was assessed using a Nanodrop® spectrophotometer), and amplification 
without reverse transcriptase was used as the control. Oligonucleotides used for RT-PCR are 230	  
presented in Table S3.  
 
Computer analysis 
Alignments of ROK-family proteins were made using ClustalW (46). This alignment was then 
used as input for the Genebee website (http://www.genebee.msu.su/clustal/basic.html) to 235	  
produce a phylogram. Shaded protein alignments were visualized using the BoxShade 
program at http://www.ch.embnet.org/software/BOX_form.html. 
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RESULTS 
 240	  
The rok-family genes in S. coelicolor 
In total 25 genes encoding proteins with a ROK-family signature are found on the S. 
coelicolor genome (2). For a phylogram see Figure 1A. The family includes glucose kinase 
(Glk; SCO2126), which catalyses the phosphorylation of glucose and plays a key role in 
carbon catabolite repression (47), and N-acetylglucosamine kinase NagK (SCO4285) (5). 245	  
Sixteen of the ROK-family proteins contain a conserved zinc-binding cysteine motif (Figure 
1B). Introduction of rep, a rok-family regulatory gene obtained from a metagenomic library, 
accelerated sporulation and enhanced antibiotic production in S. lividans (22). BlastP 
analysis of the ROK-family proteins of S. coelicolor proteins with the Rep protein sequence 
as input revealed SCO6008 as the nearest orthologue in S. coelicolor, with 48% amino acid 250	  
identity, while the next strongest hits show 30-35% amino acid identity (Table 1). However, 
the gene synteny of rep does not correspond to that of SCO6008, nor to that of any of the 
other rok genes. To analyse the possible role of the ROK-family proteins of S. coelicolor, we 
performed mutational analysis of seven rok genes (SCO0794, SCO1060, SCO2846, 
SCO6008, SCO6566, SCO6600 and SCO7543), whereby the predicted gene products, 255	  
similarly to the Rep protein, contain both a DNA binding and a zinc-binding motif and have 
not been studied previously. 
 
Gene synteny for the rok genes 
The genetic context of the rok genes studied in this work is presented in Supplemental 260	  
Figure S1. Suggestively, five out of seven genes are located in the direct proximity of one or 
more ABC transporter systems. SCO6008, previously named rok7B7 ((23, 24, 48)), is highly 
conserved in streptomycetes and is flanked by two sugar transport operons, namely 
SCO6005-6007 (upstream) and the xylose transporter operon xylFGH (SCO6009-6011; 
downstream), with its gene synteny highly conserved in streptomycetes. Rok7B7 exhibits 265	  
27% aa identity to the xylose repressor XylR of Bacillus subtilis. Rok7B7 itself shares 92% 
	   12	  
amino acid identity with NgcR of Streptomyces olivaceoviridis, which controls the upstream-
located N-acetylglucosamine and chitobiose ABC transporter operon ngcEFG (49). However, 
in S. coelicolor N-acetylglucosamine is transported via the PTS, with NagE2 and NagF as the 
membrane components EIIC and EIIB, respectively (50), while chitobiose is transported via 270	  
DasABC (51). Since SCO6005-6007 shows limited sequence similarity to NgcEFG (around 
35% aa identity), it likely transports a molecule other than N-acetylglucosamine (5, 6). 
Several of the other rok genes are also connected to ABC transporter operons. Like 
rok7B7, SCO6566 is connected to the utilization of C5 sugars, as it is located upstream of a 
likely ribose transporter operon, with conserved gene synteny in many streptomycetes. In the 275	  
direct environment of SCO1060 are two sugar transport operons, with SCO1062-1065 
possibly encoding a galactose transporter based on the phylogenetic linkage to galactose 
utilization genes (galK, galT and genes for β-galactosidases), and SCO1056-1059 with 
similarity to the maltose operon malEFG (SCO2231-2234; (52)); SCO6600 is divergently 
transcribed from sugar transport operon SCO6601-SCO6604 involved in glucoside transport 280	  
(48); SCO7543 lies adjacent to the operons SCO7539-SCO7542 and SCO7544-SCO7548. 
SCO7547-SCO7544 encode a likely sulfonate ABC transporter with similarity (37.5%, 43.4% 
and 23.3% protein identity, respectively) to TauABC of E. coli (53). 
 
Phenotypic characterization of the rok mutants 285	  
As a first step towards the characterization of the rok genes, null mutants were constructed in 
S. coelicolor M145. For this, we first replaced the entire coding region of each gene of 
interest by the apramycin cassette (aacC4) flanked by loxP sequences. For each experiment 
five transformants exhibiting the desired double-crossover phenotype (ApraR ThioS) were 
selected and verified by PCR as described in the Materials and Methods section. Following 290	  
removal of the aacC4 cassette by the Cre recombinase, deletion mutants (∆) were obtained 
and designed GAM30 (M145∆SCO0794), GAM31 (M145∆SCO1060), GAM32 
(M145∆SCO2846), GAM33 (M145∆SCO6008), GAM34 (M145∆SCO6566), GAM35 
(M145∆SCO6600) and GAM36 (M145∆SCO7543). For all experiments both the apramycin 
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resistant and the deletion mutants were analyzed. Considering that there were no phenotypic 295	  
differences between them in terms of antibiotic production and development, from this point 
onwards we will only describe the results obtained for the deletion mutants unless stated 
otherwise.  
The phenotype of all mutants was tested on MM (minimal medium) and R2YE (rich 
medium) agar plates supplemented with glycerol, mannitol, arabinose, ribose, xylose, 300	  
fructose, glucose, galactose, mannose, cellobiose, lactose, maltose, sucrose, trehalose, 
glucosamine (GlcN) or N-acetylglucosamine (GlcNAc) as the sole carbon source, while 
taurine was tested as a sulphur source considering the possible relationship between 
SCO7543 and sulphur utilization. The mutants were phenotypically similar to the parental 
strain M145 in terms of development when grown on R2YE- or MM agar plates 305	  
supplemented with fructose, sucrose, trehalose or taurine. The same was true for MM agar 
plates supplemented with mannitol or maltose, and on R2YE- supplemented with GlcNAc.  
GlcNAc activated antibiotic production of all strains under poor nutritional conditions 
(MM), while under rich growth conditions this process and aerial mycelium formation was 
blocked in all strains (Figure 2AB). This is in accordance with previous reports (8). 310	  
Furthermore, cellobiose also inhibited development and antibiotic production, and on both 
MM and R2YE grown cultures, which may be due to the repressing effect of its monomer 
glucose. Interestingly, actinorhodin production (blue pigment) and development was blocked 
for all strains grown on R2YE- agar plates with the C5 carbon source ribose and for several of 
the strains also when grown on MM with ribose (Figure 2AB). Development of all strains was 315	  
also inhibited on MM supplemented with arabinose, which is a C'-2 carbon epimer of ribose. 
Carbon-source dependence of antibiotic production (such as repression by glucose) is a 
rather well-known phenomenon (3, 54), but the effect of C5 sugars is far less well 
established.  
The most pleiotropic changes were observed in the rok7B7 mutant and to a lesser 320	  
extent the ΔSCO7543 (GAM36) mutant (Figure 2AB). Growth on MM and R2YE agar 
medium supplemented with GlcNAc did not show significant differences between M145 and 
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the rok7B7 deletion mutant, suggesting that GlcNAc transport still takes place. The rok7B7 
mutant showed delayed development and actinorhodin production on R2YE- with xylose, 
glucose, galactose, mannose, cellobiose or GlcN (Figure 2BC). Furthermore, development of 325	  
the rok7B7 mutant was delayed on MM with arabinose, and blocked on MM with ribose, 
xylose, galactose, mannose, cellobiose, lactose or GlcN (Figure 2A). Development of the 
ΔSCO7543 null mutant GAM36 was delayed under most growth conditions (Figure 2A-B). 
The other five rok gene null mutants were similar to the parent under most growth conditions 
(Figure 2AB). Considering the pleiotropic effect of the deletion of rok7B7 we subjected its null 330	  
mutant GAM33 to more extensive analysis. In a control experiment, GAM33 was 
complemented with pGAM15 harboring the rok7B7 gene and its native promoter, which 
restored the wild-type phenotype (Figure 2C). 
 
Rok7B7 controls xylose utilization and carbon catabolite repression 335	  
Considering the in silico predictions and the possible involvement of Rok7B7 in control of 
xylose utilization, we monitored growth of the rok7B7 mutant GAM33 in defined liquid mineral 
medium (MM) with mannitol (1% w/v), xylose (1% w/v) or glucose (1% w/v) as the sole 
carbon source. The rok7B7 mutant grew with a similar doubling time (Td; ~ 4 h) as that of the 
parent strain M145 in the presence of mannitol (Figure 3A). Interestingly, in MM with glucose 340	  
or xylose, GAM33 had a slightly higher growth rate than the parent M145 and reached 
significantly higher biomass levels due to postponed entry into the stationary phase (around 
six or 20 hours later for glucose and xylose, respectively), suggesting enhanced glucose and 
xylose utilization (Figure 3BC). Indeed, complementation of GAM33 with plasmid pGAM15 
harboring the rok7B7 gene and its native promoter, restored the wild-type phenotype with 345	  
reduced growth on glucose and xylose (Figure 3BC). This strongly suggests that the 
improved sugar utilization by GAM33 was solely due to the deletion of rok7B7. The 
prolonged vegetative growth phase corresponds well to the observed delay in development 
and antibiotic production on MM and R2YE agar plates supplemented with either glucose or 
xylose. The previously reported up-regulation in glucose-grown cultures of the Rok7B7 350	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protein in the glkA mutant, which is pleiotropically defective in CCR, prompted analysis of the 
role of Rok7B7 in carbon control (23). The secreted agarase produced by S. coelicolor is a 
classical CCR target and provides a simple assay (13). Therefore, agarase production by 
M145, its rok7B7 null mutant GAM33 and the complemented mutant (harbouring pGAM15), 
was compared on solid media containing mannitol, glucose, cellobiose or xylose as the sole 355	  
carbon source. The same amount of agarase was produced by all three strains on MM agar 
plates supplemented with mannitol. On MM agar plates with glucose or its dimer cellobiose, 
neither strain produced significant amounts of agarase due to efficient glucose repression 
(Figure 4 and Table 2). Interestingly, while the parental strain M145 produced normal levels 
of agarase on MM with xylose, agarase production was completely repressed in the rok7B7 360	  
mutant (Figure 4 and Table 2). Agarase production was restored following complementation 
of GAM33 with pGAM15 (Figure 4), confirming that repression did solely result from the 
inactivation of rok7B7. The rok7B7 mutant also showed enhanced CCR on MM agar plates 
with maltose or glucosamine as the sole carbon source, although not as strong as with 
xylose (Table 2). CCR was strongly enhanced in the rok7B7 mutant grown on R2YE agar 365	  
plates with various carbon sources (except glucose and cellobiose), with complete block of 
agarase production on R2YE with GlcNAc. These data suggest that Rok7B7 acts as a global 
regulator of CCR. 
 
Global transcriptional profiling of the rok7B7 null mutant by microarray analysis 370	  
To obtain insight into the global transcriptional changes as a result of the deletion of rok7B7, 
DNA microarray analysis was performed on RNA isolated from solid-grown MM mannitol 
cultures of S. coelicolor M145 and its rok7B7 null mutant GAM33. For this, plates were 
overlaid with cellophane discs and RNA was harvested after 14 h (early vegetative growth), 
24 h (corresponding to vegetative growth), 30 h (vegetative/aerial growth), 36 h (aerial 375	  
growth), 42 h (aerial growth/sporulation) and 54 h (sporulation). Under these conditions, 
which have been employed for a variety of microarray experiments with S. coelicolor, the 
mutant showed a similar timing of development as its parent. 
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The transcription of over 160 genes was more than two-fold up- or down-regulated at 
one or more time points in the rok7B7 mutant. These genes are listed in Supplemental Table 380	  
S4. Only a few targets showed over two-fold differential expression between GAM33 and the 
wild-type strain at several time points, including genes of the xylFGH operon (xylF and xylG; 
Figure 5A). Interestingly, the target that was most strongly down-regulated in the rok7B7 
mutant was SCO2494, encoding pyruvate phosphate dikinase (PPDK; SCO2494), which 
generates PEP from pyruvate. This enzyme was recently implicated to play a key role in 385	  
Glucose kinase-independent carbon control in streptomycetes (23). In support of the 
enhanced expression of xylFGH observed in the microarray data, quantitative proteomics 
experiments also showed that the components of the XylFGH transporter are about 10-fold 
increased at the protein level in the rok7B7 mutant in comparison to the parental strain M145 
(see below). Interestingly, transcription of glcP for the glucose permease GlcP (which occurs 390	  
in two identical copies glcP1 and glcP2), was strongly up-regulated at several time points 
(Figure 5A). Most of the signal observed in the microarray experiments probably stems from 
glcP1, as glcP2 is hardly expressed under any of the conditions tested, including growth on 
glucose (van Wezel et al, 2005). The genes for glucose kinase and for the glycolytic 
enzymes were not changed significantly. Besides the primary metabolic genes discussed 395	  
above, another class of genes that was deregulated in the rok7B7 null mutant was that of the 
chpABCDEFGH, rdlAB and ramS genes, which encode the surfactant proteins chaplins, 
rodlins and the spore-associated protein SapB, respectively (55, 56). All of these genes 
showed the same trend, but transcription of chpDEH and rdlAB was most strongly 
downregulated, namely over two-fold at 42 h as compared to the parental strain M145 400	  
(Supplemental Table S4). Conversely, transcription was up-regulated at 54 h. 
In a control experiment, the microarray data were further validated by semi-
quantitative RT-PCR performed on the same RNA, using oligonucleotide pairs for xylG and 
glcP1, while rpsI was the control (Figure 5B). The relative transcript levels of xylG and glcP1 
corresponded well to the microarray analysis, confirming their strong up-regulation in the 405	  
rok7B7 mutant.  
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Global protein expression profiling of the rok7B7 null mutant by proteomics 
To further study the involvement of Rok7B7 in primary metabolism, carbon catabolite 
repression and secondary metabolites biosynthesis, proteomics analysis was performed. For 410	  
this, S. coelicolor M145 and its rok7B7 mutant GAM33 were grown in liquid minimal media 
containing either 14N or 15N as the sole nitrogen source and mannitol as the sole carbon 
source, until late logarithmic phase when antibiotic production became apparent due to color 
changes of the growth medium. 14N and 15N- labeled proteins extracts were obtained from 
both the mycelium itself and the spent media. These growth conditions are very similar to 415	  
those used in the study of the glkA mutant (23), allowing direct comparison of the outcome. 
Quantitative proteomics identified 59 proteins (53 proteins in the mycelial fraction and 
seven in the secretome, with the xylose binding protein SCO6009 in both lists) whose 
expression changed with statistical significance in the rok7B7 null mutant (Figure 5C and 
Supplementary Table S5). Classes of proteins that were overrepresented were those related 420	  
to (1) primary metabolism (sugar and amino acid transport, metabolic enzymes); (2) 
siderophore biosynthesis and (3) secondary metabolism (antibiotic biosynthesis) (Figure 5C). 
 
Control of primary metabolism and CCR 
In line with the notion that Rok7B7 controls the downstream-located xylose operon 425	  
SCO6009-6011 (xylFGH), SCO6009 and SCO6010 were strongly up-regulated (9-11 fold) in 
the rok7B7 null mutant. Interestingly, glucose kinase (Glk; SCO2126) was three-fold up-
regulated in the rok7B7 mutant, while phosphoenolpyruvate carboxylase (ppc; SCO3127) 
was two-fold up-regulated These results are remarkable since no glucose is present in the 
growth medium and again links Rok7B7 to glucose utilization and carbon catabolite 430	  
repression. 
Enzymes of the pentose phosphate pathway (PPP; SCO6659-6663) were also 
significantly more abundant (4-6 fold) in the rok7B7 mutant. Considering the chromosomal 
location, SCO6658-6663 is considered as the secondary PPP cluster and may be involved in 
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providing NADPH for secondary metabolite production (57). Abundance of proteins for 435	  
glutamate import (SCO5775-5777) was two- to three-fold lower in the mutant, while those for 
import and catabolism of branched chain amino acids (SCO2008-SCO2012 and SCO2776-
2779) and an enolase (SCO7638) were two- to three-fold enhanced in the mutant. 
Furthermore, the solute binding protein SCO6005, which is a distant homologue of the NgcE 
protein that is involved in N-acetylglucosamine transport in Streptomyces olivaceoviridis (49), 440	  
was four-fold more abundant in the rok7B7 mutant.  
 
Control of siderophore and antibiotic biosynthesis 
The rok7B7 mutant shows strongly increased expression of biosynthetic proteins for the 
siderophores coelichelin (SCO0492, SCO0494, SCO0498, and SCO0499, three to five-fold 445	  
enhanced) and desferrioxamine (SCO2782 and SCO2785, two- to four-fold enhanced). 
These compounds bind extracellular iron, after which they can be reimported through ABC 
transporters (58-60). A significant number of proteins that showed differential expression in 
the rok7B7 mutant compared to M145 related to antibiotic production, namely calcium-
dependent antibiotic (CDA; SCO3230-3232, SCO3236), prodiginine (SCO5878-5896, eight 450	  
proteins detected), and a yet uncharacterized non-ribosomal peptide (SCO6431, SCO6436) 
all demonstrated increased expression levels in the rok7B7 mutant. In particular the 
biosynthetic proteins for CDA production were massively up-regulated (Figure 5C). 
To validate these data, and assess the effect of the enhanced expression of 
antibiotic-related proteins to secondary metabolite production, we subjected mycelial 455	  
samples corresponding to the samples used for proteomics to MALDI-TOF-MS analysis. S. 
coelicolor M512, which fails to produce prodigionines (), was used as a negative control. 
Interestingly, prodiginines (m/z 392 and 394) were readily detected in the rok7B7 mutant and 
approximately four-fold enhanced as compared to the parent M145 (Figure 6). This validates 
the proteomics data, demonstrating that indeed the deletion of rok7B7 results in up-460	  
regulation of antibiotic production in minimal media cultures. 
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DISCUSSION 
ROK-family proteins are widespread in actinomycetes, which are generally associated with 
the control of carbon metabolism, but except for glucose kinase (13, 23, 47, 61), study of this 465	  
promising family of regulators and (sugar) kinases is relatively scarce. Analysis of a series of 
novel rok null mutants identified rok7B7 as a likely new pleiotropic regulatory gene in S. 
coelicolor. rok7B7 null mutants showed a delay in aerial mycelium formation under most 
growth conditions, deregulation of antibiotic production and showed enhanced carbon 
catabolite repression. Deletion of the other rok genes SCO0794, SCO1060, SCO2846, 470	  
SCO6566, SCO6600 or SCO7543 had less obvious phenotypic consequences, although the 
ΔSCO7543 null mutant was somewhat affected in antibiotic production and aerial mycelium 
formation. 
The rok7B7 mutant showed strongly enhanced growth in liquid-grown cultures with 
glucose or xylose as the sole carbon source, while at the same time development and 475	  
antibiotic production were delayed in solid-grown cultures with the same carbon sources. 
This suggests that in the absence of rok7B7, the switch to development is postponed, as the 
onset of development and antibiotic production roughly correspond to transition phase in 
liquid-grown cultures (62). This corresponds well to previous data showing that Rok7B7 likely 
activates actinorhodin biosynthesis (21), Furthermore, rok7B7 is the nearest orthologue of 480	  
rep isolated from a metagenomic library, introduction of which into S. lividans accelerated 
both development and antibiotic production (22). The control of development by Rok7B7 is 
likely mediated at least in part via the control of carbon utilization, and is upregulated during 
CCR in S. coelicolor (23). Combined transcriptomic and proteomic analysis suggested that 
Rok7B7 may act as a repressor of the adjacent xylose operon xylFGH (SCO6009-6011), 485	  
since expression of the operon was strongly enhanced in the mutant. Furthermore, in a 
model whereby Rok7B7 acts as repressor, one would expect that expression of the 
components of the xylose transporter are downregulated following enhanced expression of 
Rok7B7, but recent proteomics data revealed the opposite, namely that Rok7B7 and XylFGH 
are both strongly induced in glkA deletion mutants (23). Such a direct correlation of 490	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expression is not consistent with a simple model of Rok7B7 acting as specific repressor of 
xylFGH. In fact, quantitative proteomics experiments identified XylFGH as the only sugar 
transport system that was strongly activated by glucose in a Glk-independent manner, along 
with its putative ROK-family regulator Rok7B7. We propose that the up-regulation of the 
xylose transporter operon may be an attempt to compensate for the absence of Rok7B7, 495	  
which would be consistent with a role of xylose-5P or a related metabolite, as inducer 
molecule of Rok7B7.  
In terms of the control of xylose utilization, the xylose regulator XylR of S. coelicolor is 
likely encoded by SCO1171, with the gene located adjacent to - and its gene product likely 
controlling the transcription of - xylA (SCO1169, for xylose isomerase) and xylB (SCO1170, 500	  
for xylulose kinase). XylA and XylB together catalyze the conversion from xylose to xylulose-
5P. Since there is no phylogenetic linkage between the xylABR genes and rok7B7 or 
xylFGH, and deletion of rok7B7 does not affect any of the genes SCO1169-1171, it is less 
likely that these genes belong to the rok7B7 regulon. However, to obtain full insight into the 
relationship between the regulons controlled by SCO1171/XylR and Rok7B7, the control of 505	  
xylose and xylulose metabolism needs to be investigated in more detail. It should be noted, 
however, that deletion of rok7B7 alone is sufficient to obtain strong CCR of agarase on 
xylose-containing MM agar plates, suggesting that xylose transport and utilization was 
completely derepressed in the rok7B7 mutant. A similar observation was made for the control 
of maltose utilization by MalR in S. coelicolor, where malR deletion mutants showed 510	  
complete catabolite control of agarase when maltose was used as the sole carbon source, 
while the wild-type strain hardly grows on maltose (63). 
Interestingly, the combined data suggest that deletion of rok7B7 induces glucose 
kinase-independent CCR. In other words, Rok7B7 may repress this yet poorly studied CCR 
pathway (23). The glucose transporter gene glcP was strongly up-regulated in the rok7B7 515	  
null mutant, suggesting direct control of glucose metabolism by Rok7B7. The expression of 
GlcP is strongly induced by glucose in a Glk-independent manner (23). The transmembrane 
GlcP binds to Glk, and its release during sugar transport may be a key mechanism in the 
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activation of CCR (61). The target that was most strongly down-regulated at the 
transcriptional level in the rok7B7 null mutant was SCO2494, encoding pyruvate phosphate 520	  
dikinase (PPDK; SCO2494), which generates PEP from pyruvate, the opposite of the 
reaction catalyzed by pyruvate kinase. PPDK also belongs to those proteins that are most 
strongly repressed by glucose in a Glk-independent manner (23). In fact, PPDK is some 10- 
to 30-fold down-regulated by glucose in a Glk-independent manner in both mannitol and 
fructose-grown cultures, and may play a key role in Glk-independent carbon control in 525	  
streptomycetes. The change in expression of GlcP (up-regulated) and SCO2494 (down-
regulated) by glucose in a Glk-independent manner, is consistent with cells exerting glucose 
repression, as was indeed observed for rok7B7 mutants. This is further corroborated by the 
enhanced expression of Glk in rok7B7 null mutants, as shown by the proteomics 
experiments. The fact that no significant change was found in transcription of the gene for 530	  
glucose kinase (glkA) is consistent with the constitutive transcription of glkA, and confirms 
the earlier concept that glucose kinase expression is controlled at the post-transcriptional 
level (61). All in all, our data suggest that Rok7B7 negatively controls CCR. However, despite 
our efforts using purified Rok7B7, we failed to detect direct binding of Rok7B7 to the 
promoter regions of any of the genes whose expression was most significantly affected by 535	  
the deletion of rok7B7 (data not illustrated). We therefore performed global in vivo DNA 
binding studies using ChIP-chip technology, on cultures grown under standard conditions of 
minimal media agar plates with mannitol as the sole carbon source, but this also failed to 
identify significant binding to specific sites. Therefore, we expect that a ligand or cofactor is 
required to facilitate binding of Rok7B7 to the DNA, with derivatives of xylose, cellobiose or 540	  
glucose as candidate molecules. ChIP-Chip experiments under different growth conditions 
should provide more insight into the direct Rok7B7 regulon and its binding site.  
In terms of antibiotic production, both the red-pigmented prodiginines and their 
biosynthetic proteins were enhanced in the rok7B7 mutant in liquid-grown MM cultures 
supplemented with mannitol, as shown by proteomics and subsequent MALDI-ToF MS 545	  
analysis of secondary metabolites. Conversely, in solid-grown cultures on rich media (R2YE), 
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the production of the blue-pigmented antibiotic actinorhodin was strongly delayed in the 
rok7B7 mutant, which was independent of the carbon source and consistent with earlier 
reports that Rok7B7 activates actinorhodin production (21, 22). Following a DNA-affinity 
capture assay (DACA), Rok7B7 was isolated as one of the proteins that was bound to the 550	  
promoter regions of actII-ORF4 and redD, the pathway specific transcriptional regulators of 
the act and red gene clusters, respectively (Park et al, 2009). All data point at control of 
antibiotic production by Rok7B7, with activation of Act and repression of Red and Cda. The 
proteomics experiments also showed up-regulation of the degradation pathway for branched-
chain amino acids (leucine, isoleucine and valine), which are precursors for biosynthesis of 555	  
polyketides such as actinorhodin (64), suggesting that besides antibiotic production Rok7B7 
may also control precursor supply.  
 While the C5 sugar xylose had a stimulatory effect on actinorhodin production in wild-
type cells, perhaps acting via Rok7B7, the C5 sugars arabinose and ribose, which are 
closely related compounds, suppress actinorhodin production. To the best of our knowledge 560	  
the stimulatory effect of xylose on antibiotic production was not reported previously, but the 
inhibitory effect of the C5 sugars ribose and arabinose on antibiotic production was 
established in Streptomyces hygroscopicus (65) and Streptomyces olivocinereus (66). 
Actinorhodin production is strongly delayed in the rok7B7 mutant, when grown on media 
containing xylose. As argued above, xylose or a derivative thereof (e.g. xylose-5P) may act 565	  
as an effector molecule of Rok7B7, leading to its activation and linking nutrient-sensing to 
antibiotic production and development. Antibiotic production was also repressed by 
cellobiose. Carbon-source dependence of antibiotic production is widely reported in literature 
(e.g. reviewed in (3, 54). Since cellobiose is a dimer of glucose (β-1,4), its repressing activity 
regarding antibiotic production may be explained by the accumulation of glucose produced 570	  
from its extracellular hydrolysis, thus effecting glucose repression.  
In conclusion, our work underlines the complexity of the regulatory networks involved 
in the control of antibiotic production, and highlights Rok7B7 as a novel pleiotropic 
transcriptional regulator of CCR that links the control of primary and secondary metabolism in 
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S. coelicolor. Rok7B7 therefore qualifies as a possible target for genetic engineering 575	  
approaches towards the improvement of antibiotic production. 
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Table 1. ROK regulatory genes and their knock-out strains studied in this work. The 
amino acid identities of S. coelicolor A3(2) ROK-family proteins to NagC of E.coli and Rep 
that was expressed from a metagenomic library , are presented. Protein lengths and amino 
acid (aa) identities (in %) are indicated. 
Gene 
Name of the 
null mutant 
length of gene 
product [aa] 
aa identity to NagC aa identity to Rep 
SCO0794 GAM30 429 28% 28% 
SCO1060 GAM31 413 27% 35% 
SCO2846 GAM32 406 29% 29% 
SCO6008 (rok7B7) GAM33 403 30% 48% 
SCO6566 GAM34 584 28% 33% 
SCO6600 GAM35 441 26% 30% 
SCO7543 GAM36 424 27% 34% 
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Table 2. Rok7B7 and carbon catabolite repression of agarase production. 
  
  M145 ∆rok7B7 (GAM33)   
MM 
agarase # 
[mm] 
total* 
[mm] ratio# 
agarase 
[mm] 
total* 
[mm] ratio# fold^ 
Agar 6 26 0.23 6 26 0.23 1 
Mannitol 5 25 0.2 5 25 0.2 1 
GlcN 5 23 0.22 3 19 0.16 0.73 
Fructose 6 26 0.23 6 25 0.24 1.04 
Maltose 6 26 0.23 5 26 0.19 0.83 
GlcNAc 5 26 0.19 5 26 0.19 1 
Glucose 1 17 0.06 1 17 0.06 1 
Xylose 5 25 0.2 0 15 0 0 
Chitin 6 26 0.23 6 27 0.22 0.96 
Cellobiose  1   17 0.06  1  17   0.06 1  
R2YE 
agarase 
[mm] 
total* 
[mm] ratio# 
agarase 
[mm] 
total* 
[mm] ratio# fold^ 
Agar 5 22 0.23 1 15 0.07 0.29 
Mannitol 5 22 0.23 1.5 16 0.09 0.41 
GlcN 5 22 0.23 1.5 16 0.09 0.41 
Fructose 5 23 0.22 2 17 0.12 0.54 
Maltose 5 22 0.23 3 20 0.15 0.66 
GlcNAc 2 17 0.12 0 14 0 0 
Glucose 1 18 0.06 1 18 0.06 1 
Xylose 5 25 0.2 2 17 0.12 0.59 
Chitin 5 22 0.23 2 17 0.12 0.52 
Cellobiose 1 18 0.06 1 18 0.06 1 
 
# agarase: agarase zone in millimetres, measured from the outside of the colony to the edge 
of the zone of clearing; * total: combined length of agarase zone and colony; # Ratio: length 
of agarase zone and the combined length of agarase zone and colony; ^ Fold: ratio of 
∆rok7B7 / ratio of M145. 
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FIGURE LEGENDS 
 
Figure 1. Phylogeny of the predicted ROK family proteins of S. coelicolor M145 and 
alignment of Cys motifs. (A) Phylogram of the ROK proteins of S. coelicolor based on 
ClustalW analysis (46). ROK-family proteins containing a conserved zinc-binding motif are 
marked by asterisks. The names of proteins with known or suspected function are given. (B) 
Alignment of the partial aa sequences of the ROK-family proteins that contain the zinc-
binding motif, with B. subtilis XylR and E. coli NagC included for reference purposes. 
Asterisks refer to the conserved Cys and His residues that coordinate the Zinc atom. For 
shading, at least 50% of the aligned proteins should share the same or similar aa residues. 
Identical residues shaded black, similar residues shaded grey.  
 
Figure 2. Phenotypic analysis of the rok mutants. Phenotypes of S. coelicolor M145 and 
its ΔSCO0794, ΔSCO1060, ΔSCO2846, ΔSCO6008 (Δrok7B7), ΔSCO6566, ΔSCO6600, 
ΔSCO7543 mutants (designated GAM30 to GAM36, respectively) were tested on (A) MM 
and (B) R2YE microtitre plates supplemented with 1% (w/v) of carbon sources as indicated. 
Cultures were grown for 120 hr (C) Complementation of the rok7B7 mutant GAM33 with 
pGAM15 harbouring the rok7B7 gene and its native promoter. Phenotypes were analysed on 
R2YE agar plates supplemented with 1% (w/v) of mannitol, glucose or xylose. Cultures were 
grown for 72 hr. Note that development of the rok7B7 mutant is delayed on R2YE glucose 
and not completely blocked, and after 120 hr normal sporulation occurred (see Figure 2B). 
  
Figure 3. Growth curves in minimal media with various carbon sources. The wild-type 
strain M145 (solid line), GAM33 (Δrok7B7) (dashed line) and the complemented mutant 
GAM33/pGAM15 (dashed/dotted line) were grown in MM supplemented with (A) mannitol (B) 
glucose or (C) xylose. tD, doubling time. All growth analyses were performed in duplicate. 
The standard deviation for each data point is indicated. 
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Figure 4. Effects of mannitol, glucose, cellobiose and xylose on agarase production. 
Strains were M145 (parental strain), its rok7B7 null mutant GAM33 and GAM33 
complemented with pGAM15 (harbouring rok7B7). 5 µl of spores of either strain (109 cfu/ml) 
was spotted onto MM plates. After three days of growth the agarase production was detected 
as a zone of clearing of the agar around the mycelial spot and related to the biomass. (for 
details see Table 2 and (63)). 
 
Figure 5. Transcriptomic and proteomic analysis of S. coelicolor rok7B7 mutant. (A) 
Genes whose transcription was significantly differentially expressed between the rok7B7 null 
mutant (GAM33) and its parent S. coelicolor M145. RNA was isolated from S. coelicolor 
M145 or its rok7B7 mutant GAM33 after 14h (early vegetative growth), 24 h (vegetative 
growth), 30 h (vegetative/aerial growth), 36 h (aerial growth), 42 h (aerial growth/sporulation) 
and 54 h (sporulation) of growth on MM agar plates supplemented with 1% mannitol. The 
heat map indicates the fold changes. (B) Validation of microarray data by semi-quantitative 
RT-PCR. RT-PCR was performed on RNA isolated form the parental strain M145 and the 
rok7B7 mutant, using oligonucleotide pairs for a selection of targets (xylG,glcP1). rpsI (for 
ribosomal protein S9) was used as a control. (C) Differentially expressed proteins between 
the rok7B7 mutant and wild type. Quantitative proteomic comparison of rok7B7 deletion 
strain and parent strain (M145). Strains were grown in liquid MM supplemented with 
mannitol. The comparison between strains is indicated as ratios of Δrok7B7/M145. Results 
are given as log2 ratio, therefore positive number indicate up-regulation. 
 
Figure 6. MALDI-ToF analysis of prodiginine production. Production of prodigionines 
(Red) was analysed in mycelia of M145, GAM33 and M512. Arrows correspond to the 392 
and 394 Da peaks for Red. Horizontal axis, m/z (Da); vertical axis, intensity (arbitrary units). 
 
Figure 7. Model for the Rok7B7 regulatory network. Our data show that active Rok7B7 
(indicated with an asterisk) activates actinorhodin (Act) production and development (as 
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shown previously for its orthologue Rep (22)), which explains the delayed development and 
Act production in the rok7B7 null mutant. Conversely, the production of the secondary 
metabolites Red, Cda and siderophores is upregulated. Deletion of rok7B7 results in 
enhanced expression of GlcP, Glk and XylFGH as well as induction of CCR (including Glk-
independent CCR). During glucose utilization, Glk is likely posttranslationally activated 
(shown as Glk*), resulting in CCR (11). Solid lines, conversion or pathway; dotted lines, 
regulation (arrows represent activation, large dots indicate repression). We speculate that a 
metabolic derivative of xylose, such as xylose-5P, acts as ligand for Rok7B7, thus activating 
the protein. 
 







